Peking University Cancer Hospital & Institute: all 266 studies

Page 3 of 3. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast CancerStatus unknownNCT04192331Phase 2
• Toripalimab in Combination With Axitinib in Patients With Localized Mucosal MelanomaStatus unknownNCT04180995Phase 2
• Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal LesionsStatus unknownNCT04170257Not applicable
• Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT04137588
• A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLCStatus unknownNCT04023617Phase 2
• PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral MelanomaStatus unknownNCT03955354Phase 2
• Phase II Study in the Treatment of Patients With Advanced Mucinous MelanomaStatus unknownNCT03941795Phase 2
• Nab-PCE vs PC for MM After Failure of Anti-PD-1Status unknownNCT03917069Phase 2
• RSYR for Fatigue Reduction in Cancer SurvivorsCompletedNCT03911921Phase 2
• Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in ChinaStatus unknownNCT03792529
• Anlotinib in Treatment of Recurrent Small Cell Lung CancerStatus unknownNCT03732846Phase 2
• Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using MammographyCompletedNCT03708978
• Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGCStatus unknownNCT03708783Not applicable
• Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal GastrectomyStatus unknownNCT03613142Not applicable
• Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene AberrationsStatus unknownNCT03454919Phase 2
• SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer PatientsStatus unknownNCT03448549Phase 3
• HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal MelanomaStatus unknownNCT03435302Phase 3
• Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerCompletedNCT03425058
• A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced MelanomaStatus unknownNCT03422445Phase 2
• Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLCStatus unknownNCT03402464Phase 2
• Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal CancerStatus unknownNCT03286920
• Compare the Aesthetic Effect of Different ThyroidectomiesCompletedNCT03239769Not applicable
• Prediction of Lymphatic Metastasis in Esophageal Cancer by CT RadiomicsCompletedNCT03237130
• Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)Status unknownNCT03199989Phase 3
• The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular CarcinomaStatus unknownNCT03143140Not applicable
• Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung CancerCompletedNCT03113851Phase 2
• Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic MelanomaStatus unknownNCT03095079Phase 2
• 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell LymphomaStatus unknownNCT03051581Not applicable
• Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell LymphomaStatus unknownNCT03051568Not applicable
• 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell LymphomaStatus unknownNCT03051555Not applicable
• Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell LymphomaStatus unknownNCT03051542Not applicable
• Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver MetastasisCompletedNCT03031444Phase 2/3
• Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung CancerStatus unknownNCT02942043Phase 2
• Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell LymphomaStatus unknownNCT02931201Not applicable
• 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell LymphomaStatus unknownNCT02928861Not applicable
• Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerTerminatedNCT02867839Phase 3
• Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal CancerCompletedNCT02864849Phase 2
• Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant TreatmentCompletedNCT02860234
• Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal CarcinomaCompletedNCT02850991Not applicable
• A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GISTStatus unknownNCT02776878Not applicable
• Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After ResectionStatus unknownNCT02767375Phase 2/3
• A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma PatientsStatus unknownNCT02727309Phase 1/2
• Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid CancerCompletedNCT02724176Not applicable
• A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma PatientsStatus unknownNCT02619058Phase 1
• Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer PatientsStatus unknownNCT02500810Phase 2
• Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric CancerStatus unknownNCT02464215Not applicable
• A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver NeoplasmsStatus unknownNCT02413437Not applicable
• A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.Status unknownNCT02398552Phase 2
• Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer PatientsStatus unknownNCT02330783Phase 2
• Blood Detection of EGFR Mutation For Iressa TreatmentStatus unknownNCT02282267Not applicable
• Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive SystemStatus unknownNCT02233205Phase 1/2
• Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in VitroStatus unknownNCT02226224
• Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)Status unknownNCT02179528Phase 2
• DNA Methylation Biomarkers and Metastasis of Gastric CarcinomaCompletedNCT02159339
• Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal MelanomaStatus unknownNCT02023710Phase 2
• Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety StudyStatus unknownNCT01960829Phase 2
• A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated MelanomaStatus unknownNCT01782508Phase 2
• Sorafenib Combined With Chemotherapy for Renal Collecting Duct CarcinomaCompletedNCT01762150Phase 2
• Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01395056
• Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionCompletedNCT01256801
• Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01232062
• Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)CompletedNCT01231022
• Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast CancerCompletedNCT01199393
• Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to ChemotherapyCompletedNCT01198301
• Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)Status unknownNCT01180153Phase 2
• Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisStatus unknownNCT01167049Phase 2

← Peking University Cancer Hospital & Institute overview and focus areas